0102030405
Trifluoroacetyl Tripeptide-2 An Active Peptide Specifically Designed For High-end Eye Care.
01
Product Description
1. MOA
Trifluoroacetyl Tripeptide-2 is a synthetic, biomimetic peptide specifically engineered for targeted anti-aging, with a primary focus on the delicate periorbital area (around the eyes). Its mechanism of action is sophisticated and multi-faceted, centered on improving dermal-epidermal junction (DEJ) integrity and modulating key structural proteins.
Reinforcement of the Dermal-Epidermal Junction (DEJ): The peptide acts as a signal molecule to help reinforce the DEJ, the critical basement membrane zone that connects the epidermis to the dermis. A strong DEJ is essential for overall skin firmness and youthful architecture. With age, the DEJ flattens, leading to sagging. Trifluoroacetyl Tripeptide-2 helps combat this by promoting the organization and strength of the DEJ structures.
Stimulation of Laminin and Collagen IV: It specifically upregulates the synthesis of Laminin V and Collagen Type IV, which are the primary structural components of the DEJ. This action "anchors" the epidermis more effectively to the dermis, resulting in a visible lifting and firming effect, particularly on the upper eyelid.
Modulation of Tenascin-X: The peptide influences the expression of Tenascin-X, an extracellular matrix glycoprotein crucial for maintaining the elasticity and integrity of collagen fibers. This further contributes to improved skin firmness and resilience.
2. In Vitro Efficacy Data
DEJ Protein Synthesis: In vitro studies on human skin models demonstrated a significant increase in the production of key DEJ proteins, including Laminin V (increase of over 200%) and Collagen IV.
Tenascin-X Expression: Research confirmed the upregulation of Tenascin-X, supporting the ingredient's role in enhancing the structural organization of the dermal matrix.
Human Fibroblast Activity: Tests showed that Trifluoroacetyl Tripeptide-2 actively promotes fibroblast function, leading to a healthier and more robust extracellular matrix.
3. Clinical Results
Clinical studies on human volunteers validate the in vitro findings, demonstrating measurable and visible improvements in eyelid sagging and overall eye area appearance.
Eyelid Lift & Contour Improvement: In a clinical trial, a formula containing Trifluoroacetyl Tripeptide-2 applied twice daily for 56 days resulted in a measurable lifting of the upper eyelid by an average of 0.8 mm, as confirmed by photographic analysis and ophthalmologic measurements. This translates to a more open, youthful, and alert eye contour.
Reduction in Drooping: Participants showed a significant improvement in the appearance of sagging and heavy-looking eyelids.
Overall Firmness: Subjective self-assessment by volunteers reported a noticeable improvement in the firmness and tightness of the skin around the eyes.
Safety Profile
Trifluoroacetyl Tripeptide-2 is designed for high tolerability. It is non-irritating and non-sensitizing to the sensitive skin of the eye area when used at recommended concentrations. It has an excellent safety record in cosmetic formulations.
Compatibility
Synergistic Combinations:
*Caffeine: To help reduce puffiness and dark circles through vasoconstriction and drainage. *Hyaluronic Acid: To provide immediate hydration and smooth out surface wrinkles (e.g., crow's feet).
*Dipeptide-2: To further target dark circles by improving microcirculation. *Other Peptides (e.g., Palmitoyl Tripeptide-38): For a comprehensive approach to dermal matrix rejuvenation.
Formulation Stability: It is stable under standard cosmetic pH conditions and is suitable for both aqueous and anhydrous glycol-based systems.
*Caffeine: To help reduce puffiness and dark circles through vasoconstriction and drainage. *Hyaluronic Acid: To provide immediate hydration and smooth out surface wrinkles (e.g., crow's feet).
*Dipeptide-2: To further target dark circles by improving microcirculation. *Other Peptides (e.g., Palmitoyl Tripeptide-38): For a comprehensive approach to dermal matrix rejuvenation.
Formulation Stability: It is stable under standard cosmetic pH conditions and is suitable for both aqueous and anhydrous glycol-based systems.
01
Recommended Dosage & Formulations
Recommended Usage Level: 5 to 50 ppm (0.0005% - 0.005%). It is an extremely potent ingredient, effective at very low concentrations.
Suitable Formulations: This ingredient is specifically designed for targeted treatments for the eye area and firming products.
Eye Serums & Gels
Eye Contour Creams
Targeted Lift & Firming Serums (for eyelids, jawline)
Concentrated Ampoules
01
Targeted Action for Eyelid Sagging
Uniquely engineered to address the specific concern of upper eyelid drooping, a key sign of aging that is difficult to treat with topicals.
01
Clinically Proven Eyelid Lift
Supported by irrefutable clinical data showing a measurable lifting effect (in millimeters), providing a powerful "before and after" story.
03
Reinforces Skin's Foundation
Works at the fundamental level of the DEJ to strengthen the skin's infrastructure for lasting firmness.
03
Extreme Potency
Offers high efficacy at very low doses (ppm level), making it a cost-effective active for premium formulations.
03
Safe for the Delicate Eye Area
Specifically tested and proven to be non-irritating for the most sensitive skin zone.
03
Strong Marketing Angle
The "non-surgical eyelid lift" or "eyelid contouring" claim is a highly compelling and unique selling proposition in the anti-aging market.
Storage
Store in a closed container at a dry place at room temperature.
Animal Testing
Not animal tested
Vegan
Does not contain animal-derived components
GMO
No data available